Get started
SHENZHEN HEPALINK PHARMACEUTICALSHENZHEN HEPALINK PHARMACEUTICALSHENZHEN HEPALINK PHARMACEUTICAL

SHENZHEN HEPALINK PHARMACEUTICAL

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

9989 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the research, production and distribution of heparin sodium bulk drugs. It offers heparin sodium products including Food and Drug Administration (FDA) grade heparin sodium ingredients and ordinary grade heparin sodium ingredients. The company was founded by Li Tan, Li Li and Shan Yu on April 21, 1998 and is headquartered in Shenzhen, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

9989 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company